IP
AGTC

Intellectus Partners’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Intellectus Partners’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,000
Closed -$80K – 563
2018
Q3 		$80K Buy
11,000
+2,000
+22% +$8.76K 0.03% 304
2018
Q2 		$33K Buy
9,000
+6,000
+200% +$27.8K 0.01% 380
2018
Q1 		$12K Buy
3,000
+1,000
+50% +$4.2K ﹤0.01% 464
2017
Q4 		$7K Buy
+2,000
New +$7.55K ﹤0.01% 519

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.72B AUM 7.92% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Intellectus Partners's AGTC Position: Q4 2018 in Review

Intellectus Partners sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2018, closing a stake of 11,000 shares — an estimated $80K sold.

Intellectus Partners first reported a position in AGTC in Q4 2017 and held it in 4 quarters. The position peaked at $80K in Q3 2018. 54 funds tracked by Wall St. Rank hold AGTC as of Q4 2018.

  • Intellectus Partners reported no remaining Applied Genetic Technologies Corporation position as of Q4 2018 after selling out during the quarter.
  • Intellectus Partners sold 11,000 Applied Genetic Technologies Corporation shares in Q4 2018, an estimated $80K.
  • Intellectus Partners first reported a position in Applied Genetic Technologies Corporation in Q4 2017 and held it in 4 quarters.
  • Intellectus Partners's Applied Genetic Technologies Corporation position peaked at $80K in Q3 2018.
  • 54 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2018.

Based on Intellectus Partners's 13F filing for Q4 2018, filed 14 Feb 2019.